Latest news
Akebia Therapeutics Q2 Earnings Call Highlights - TradingViewTradingView · Wed, 05 Aug 2026 22:03:49 GMTAKBA: Vafseo revenue and patient growth accelerated, offsetting AURYXIA declines amid robust pipeline progress - TradingViewTradingView · Wed, 05 Aug 2026 21:53:37 GMTAkebia Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:38:29 GMTAkebia Therapeutics 2Q 2026: Revenue $49.1M, EPS $(0.03) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:26:35 GMTAKBA: Vafseo's strong growth offset Auryxia's decline, but total revenues and net income fell year-over-year - TradingViewTradingView · Wed, 05 Aug 2026 20:17:59 GMTAKBA Q2'26 Earnings: EPS estimate is (0.04) USD - TradingViewTradingView · Tue, 04 Aug 2026 11:01:27 GMT